Multidrug-resistant Tuberculosis, People's Republic of China, 2007-2009

Emerging Infectious Diseases

Volumn 17, Issue 10, 2011, Pages 1831-1838

  He, Guang Xue ^a,b   Wang, Hai Ying ^c   Borgdorff, Martien W ^b   van Soolingen, Dick ^d   van der Werf, Marieke J ^b,e   Liu, Zhi Min ^c   Li, Xue Zheng ^c   Guo, Hui ^a   Zhao, Yan Lin ^a   Varma, Jay K ^f   Tostado, Christopher P ^g   van den Hof, Susan ^b,e  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Shandong Provincial Tuberculosis Control Center   (China)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGRICULTURAL WORKER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; FEMALE; GENOTYPE; HEALTH INSURANCE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; RISK FACTOR; SOCIAL STATUS; STUDENT; SYMPTOM;

EID: 84930473877     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1710.110546     Document Type: Article

References (40)

1. World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007; 2010 [cited 2011 Apr 27]. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
2. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009; 2009 [cited 2011 Apr 27]. http://whqlibdoc.who.int/publications/2009/9789241563802_eng_doc.pdf
3. Ministry of Health of the People's Republic of China. Nationwide anti-tuberculosis drug resistant baseline surveillance in China (2007-2008) [in Chinese]. Beijing: People's Public Health Press, 2010.
4. Crofton J, Chaulet P, Maher D. Guidelines for the management of drugresistant tuberculosis. 1997 [cited 2011 Apr 27]. http://whqlibdoc.who.int/hq/1997/WHO_TB_96.210_(Rev.1).pdf
5. World Health Organization. The global MDR-TB & XDR-TB response plan, 2007-2008. 2007 [cited 2011 Apr 27]. http://libdoc.who.int/hq/2007/WHO_HTM_TB_2007.387_eng.pdf
6. Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13:380-7. doi:10.3201/ eid1303.061400
7. Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, et al. Impact of extensive drug resistance on treatment outcomes in non- HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2007;45:1290-5. doi:10.1086/522537
8. Mi FL, Wang LX, Li L, Li RZ, Zhang H, Jiang SW, et al. Effect analysis of China Global Fund multi-drug resistant tuberculosis project. Chinese Journal of Antituberculosis. 2011;32:700-4.
9. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008; WHO/ HTM/TB/2008.402. 2008 [cited 2011 Apr 28]. http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf
10. World Health Organization, International Union against Tuberculosis and Lung Disease. Anti-tuberculosis drug resistance in the world. Report no. 3: prevalence and trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Geneva: The Organization; 2004.
11. Li Z, Kelley C, Collins F, Rouse D, Morris SA. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis. 1998;177:1030-5.
12. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science. 2006;312:1944-6. doi:10.1126/science.1124410
13. van Doorn HR, Claas ECJ, Templeton KE, van der Zanden AGM, te Koppele Vije A, de Jong MD, et al. Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. J Clin Microbiol. 2003;41:4630-5. doi:10.1128/JCM.41.10.4630-4635.2003
14. Kenyon TA, Ridzon R, Luskin-Hawk R, Schultz C, Paul WS, Valway SE, et al. A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med. 1997;127:32-6.
15. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, et al. Origin and interstate spread of a New York City multidrug- resistant Mycobacterium tuberculosis clone family. JAMA.1996;275:452-7. doi:10.1001/jama.275.6.452
16. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis. 2010;10:103-11. doi:10.1016/S1473-3099(09)70330-5
17. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843-9.
18. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293:2726-31. doi:10.1001/jama.293.22.2726
19. van Rie A, Warren RM, Beyers N, Gie RP, Classen CN, Richardson M, et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among non-institutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis. 1999;180:1608-15. doi:10.1086/315054
20. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. High incidence of the Beijing genotype among multidrug- resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis. 2005;40:881-6. doi:10.1086/427940
21. Devaux I, Kremer K, Heersma H, Van Soolingen D. Clusters of multidrug- resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis. 2009;15:1052-60. doi:10.3201/eid1507.080994
22. Devaux I, Manissero D, Fernandez de la Hoz K, Kremer K, van Soolingen D, EuroTB network. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007. Euro Surveill. 2010;15:pii:19518.
23. van Soolingen D, Kremer K. Findings and ongoing research in the molecular epidemiology of tuberculosis [in Japanese]. Kekkaku.2009;84:83-9.
24. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
25. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol.2006;44:4498-510. doi:10.1128/JCM.01392-06
26. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A. 2002;99:3684-9. doi:10.1073/pnas.052548299
27. Tsolaki AG, Gagneux S, Pym AS, Yves-Olivier L, Goguet de la Salmoniere Y-OL, Kreiswirth BN, et al. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol. 2005;43:3185-91. doi:10.1128/JCM.43.7.3185-3191.2005
28. Deng Y, Wang Y, Wang JL, Jing H, Yu CB, Wang HY, et al. Laboratory- based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis. 2011;17:495-7.
29. Sun Q, Meng Q, Yip W, Yin X, Li H. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis. 2008;12:625-30.
30. He GX, Zhao YL, Jiang GL, Liu YH, Xia H, Wang SF, et al. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis. 2008;8:166. doi:10.1186/1471-2334-8-166
31. van Soolingen D, Hermans PWM, de Haas PEW, Soll DR, van Embden JDA. The occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of insertion- dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol. 1991;29:2578-86.
32. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol. 1988;26:2465-6.
33. Samper S, Iglesias MJ, Rabanaque MJ, Gómez LI, Lafoz MC, Jiménez MS, et al; The Spanish Working Group on MDR-TB. Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain. J Clin Microbiol.2005;43:1220-7. doi:10.1128/JCM.43.3.1220-1227.2005
34. Rivero A, Marquez M, Santos J, Pinedo A, Sanchez MA, Esteve A, et al. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis. 2001;32:159-61. doi:10.1086/317547
35. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843-9.
36. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. High incidence of the Beijing genotype among multidrug- resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis. 2005;40:881-6. doi:10.1086/427940
37. Li X, Xu P, Shen X, Qi LH, DeRiemer K, Mei J, et al. Non-Beijing strains of Mycobacterium tuberculosis in China. J Clin Microbiol.2011;49:392-5. doi:10.1128/JCM.00754-10
38. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293:2726-31. doi:10.1001/jama.293.22.2726
39. Glynn JR, Vynnycky E, Fine PEM. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol.1999;149:366-71.
40. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis. 2002;8:363-9. doi:10.3201/eid0804.000444